[A Case of Gastric Cancer with Ramucirumab-Related Colon Perforation after a Subtotal Colectomy]

Gan To Kagaku Ryoho. 2019 Dec;46(13):2066-2068.
[Article in Japanese]

Abstract

A 61-year-old man with advanced gastric cancer underwent distal gastrectomy after chemotherapy. Fifteen months later, peritoneal metastasis and colon stenosis were detected. Therefore, subtotal colectomy and ileosigmoidostomy were performed. Three weeks later, paclitaxel(PTX)treatment was initiated, followed by nab-PTX with ramucirumab(Ram)treatment at 7 weeks postoperatively. The patient experienced sudden abdominal pain diagnosed as gastrointestinal perforation 13 weeks postoperatively. Operative findings showed that the anastomosis of the ileosigmoidostomy was perforated, and this was treated using sutures. Angiogenesis inhibitors should be carefully administered even 4 weeks or more after surgery.

Publication types

  • Case Reports

MeSH terms

  • Antibodies, Monoclonal, Humanized / adverse effects*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Colectomy
  • Gastrectomy
  • Humans
  • Intestinal Perforation / chemically induced
  • Intestinal Perforation / surgery*
  • Male
  • Middle Aged
  • Paclitaxel
  • Ramucirumab
  • Stomach Neoplasms* / drug therapy

Substances

  • Antibodies, Monoclonal, Humanized
  • Paclitaxel